These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ectopic production of big ACTH in carcinoma of the lung. Its clinical usefulness as a biologic marker. Ayvazian LF; Schneider B; Gewirtz G; Yalow RS Am Rev Respir Dis; 1975 Mar; 111(3):279-87. PubMed ID: 164143 [TBL] [Abstract][Full Text] [Related]
4. Tumour ACTH concentrations in ectopic ACTH syndrome and in control tissues. Knight RA; Ratcliffe JG; Besser GM Proc R Soc Med; 1971 Dec; 64(12):1266-7. PubMed ID: 4331882 [No Abstract] [Full Text] [Related]
5. Multiple forms of corticotropin (adrenocorticotropic hormone, ACTH) and their significance. Yalow RS Ciba Found Symp; 1976; 41():159-81. PubMed ID: 181223 [TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro. Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033 [TBL] [Abstract][Full Text] [Related]
7. Human NH2 terminal of pro-opiomelanocortin as a potential marker for pulmonary carcinoma. Chan JS; Seidah NG; Chrétien M Cancer Res; 1983 Jul; 43(7):3066-9. PubMed ID: 6303575 [TBL] [Abstract][Full Text] [Related]
8. Pro-opiomelanocortin expression in a metastatic breast carcinoma with ectopic ACTH secretion. Pelte MF; Schwaller J; Cerrato C; Meier CA Breast J; 2004; 10(4):350-4. PubMed ID: 15239795 [TBL] [Abstract][Full Text] [Related]
9. Small cell lung carcinoma with ectopic adrenocorticotropic hormone and antidiuretic hormone syndromes: a case report. Suzuki H; Tsutsumi Y; Yamaguchi K; Abe K; Yokoyama T Jpn J Clin Oncol; 1984 Mar; 14(1):129-37. PubMed ID: 6323789 [TBL] [Abstract][Full Text] [Related]
10. Cushing's syndrome following ectopic neoplastic production of corticotropin. (Report of 4 cases studied by clinical and biochemical methods, and by microscopic and macroscopic anatomy). Evertz W; Pfeiffer EF Horm Metab Res; 1970 Jul; 2(4):213-20. PubMed ID: 4364404 [No Abstract] [Full Text] [Related]
11. The nature of the immunoreactive lipotropins in human plasma and tissue extracts. Tanaka K; Nicholson WE; Orth DN J Clin Invest; 1978 Jul; 62(1):94-104. PubMed ID: 659643 [TBL] [Abstract][Full Text] [Related]
13. Ectopic adrenocorticotropin (ACTH) and corticotropin-releasing hormone (CRH) production in the adrenal gland: basic and clinical aspects. Vrezas I; Willenberg HS; Mansmann G; Hiroi N; Fritzen R; Bornstein SR Microsc Res Tech; 2003 Jun; 61(3):308-14. PubMed ID: 12768546 [TBL] [Abstract][Full Text] [Related]
14. Infrequent elevation of plasma ACTH in patients with bronchogenic carcinoma. Davis S; May PB Am J Med Sci; 1982; 283(1):2-7. PubMed ID: 6275702 [TBL] [Abstract][Full Text] [Related]
15. The production of markers by bronchogenic carcinoma: a review. Primack A Semin Oncol; 1974 Sep; 1(3):235-44. PubMed ID: 4143486 [No Abstract] [Full Text] [Related]
16. Efficacy of using basal plasma adrenocorticotropic hormone-radioimmunoassay (ACTH-RIA) level in the identification of the cause of Cushing's syndrome. Sriussadaporn S; Ploybutr S; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A J Med Assoc Thai; 1997 Apr; 80(4):233-41. PubMed ID: 9175392 [TBL] [Abstract][Full Text] [Related]
17. [Case of ectopic ACTH-producing small cell carcinoma of the lung: a reduction in tumor size after chemotherapy in spite of a marked rise in the plasma ACTH level]. Yoshino K; Sarui H; Yamada K; Shibata T; Daido H; So T; Takuno Y; Ishizuka T; Yasuda K; Yoshimura M; Hara A Nihon Naika Gakkai Zasshi; 1997 Apr; 86(4):684-6. PubMed ID: 9198663 [No Abstract] [Full Text] [Related]
18. Small cell carcinoma of the vagina causing Cushing's syndrome by ectopic production and secretion of ACTH: a case report. Colleran KM; Burge MR; Crooks LA; Dorin RI Gynecol Oncol; 1997 Jun; 65(3):526-9. PubMed ID: 9190988 [TBL] [Abstract][Full Text] [Related]
19. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Mukherjee A; Murray RD; Teasdale GM; Shalet SM Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963 [TBL] [Abstract][Full Text] [Related]